William, W. N., Papadimitrakopoulou, V., Lee, J. J., Mao, L., Cohen, E. E., Lin, H. Y., . . . Lippman, S. M. (2016). Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol.
Chicago-стиль цитированияWilliam, William N., et al. "Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial." JAMA Oncol 2016.
MLA-цитированиеWilliam, William N., et al. "Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial." JAMA Oncol 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.